METHODS: The translated PFDI-20 and PFIQ-7 were administered to parous Luganda-speaking women and readministered 4-8 months after. The Pelvic Organ Prolapse Quantification (POP-Q) examination determined the presence of pelvic organ prolapse (POP) and a cough-stress test (CST) measured urinary leakage. Analysis was completed using Cronbach\'s α co-efficient for internal consistency and Spearman\'s correlation coefficients and Wilcoxon rank sum tests for construct validity.
RESULTS: Of the 159 participants, 93 (58.3%) had stage II POP or higher. The PFDI-20 and PFIQ-7 demonstrated minimal bother and impact on activities of daily living respectively. The Urinary Distress Inventory 6 (UDI-6) scores on the PFDI-20 showed a strong positive association with the presence of urinary incontinence. When PFD was defined by responses to symptom assessment, the translated PFDI-20 and PFIQ-7 could differentiate between individuals with and without PFD.
CONCLUSIONS: The UDI-6 section of the PFDI-20 was found to be valid in Luganda. The PFIQ-7 and the entirety of the PFDI-20 were not found to be reliable or valid, likely because of the low prevalence of PFDs in the study population.
方法:将翻译的PFDI-20和PFIQ-7给讲卢甘达语的女性服用,并在4-8个月后再次服用。盆腔器官脱垂定量(POP-Q)检查确定了盆腔器官脱垂(POP)的存在,咳嗽压力测试(CST)测量了尿漏。使用Cronbach的α系数进行内部一致性分析,Spearman的相关系数和Wilcoxon秩和检验进行结构效度分析。
结果:在159名参与者中,93例(58.3%)患有II期或更高的POP。PFDI-20和PFIQ-7分别对日常生活活动的困扰和影响最小。PFDI-20上的尿失禁清单6(UDI-6)得分显示与尿失禁的存在有很强的正相关。当通过对症状评估的反应来定义PFD时,翻译的PFDI-20和PFIQ-7可以区分有和没有PFD的个体。
结论:发现PFDI-20的UDI-6部分在卢甘达有效。PFIQ-7和整个PFDI-20没有被发现是可靠或有效的,可能是因为PFDs在研究人群中的患病率较低。